Back to Creative Planning Creative Planning

ACRS

12 quarters

Position history for Creative PlanningCreative Planning's holdings in Aclaris Therapeutics, Inc.

Yes. Creative Planning holds 258,367 shares of ACRS (Aclaris Therapeutics), worth $1.4M, as of its Q3 2026 13F filing. It increased the position by 51,720 shares (+25.0%) from Q2 2026. Creative Planning has held ACRS since Q4 2025, across 4 quarterly 13F filings.

Current Value

$1.4M

Current Shares

258,367

Total Value Change

+$1.3M

Total Shares Change

+228,291

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
258,367
+25.0%
$1.4M0.0%$5.26
31
2026-Q2
Increased
206,647
+35.9%
$1.1M0.0%$5.29
33
2026-Q1
Increased
152,088
+197.2%
$570,3300.0%$3.75
39
2025-Q4
New
51,171
-
$154,0250.0%$3.01
31
2021-Q2
Exited
0
-100.0%
$00.0%$17.56
0
2021-Q1
Decreased
17,740
-13.5%
$447,0000.0%$25.20
0
2020-Q4
Decreased
20,500
-31.7%
$133,0000.0%$6.47
0
2020-Q3
Decreased
30,000
-0.3%
$77,0000.0%$2.57
0
2020-Q2
Unchanged
30,076
0.0%
$49,0000.0%$1.62
0
2020-Q1
Unchanged
30,076
0.0%
$31,0000.0%$1.04
0
2019-Q4
Unchanged
30,076
0.0%
$57,0000.0%$1.89
0
2019-Q3
New
30,076
-
$32,0000.0%$1.08
27

Other major holders of ACRS: Wellington Management Group LLP, Adage Capital Partners GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used